CYP2J2 and pulmonary arterial hypertension: In addition, CYP2J2 overexpression can reduce monocrotaline induced PAH in rats [16] and inhibit TNF-α-induced apoptosis of pulmonary artery endothelial cells and TGF-β1-induced proliferation and migration of pulmonary artery smooth muscle cells [17].